Abstract
Introduction
Anti-neutrophil cytoplasmic autoantibodies (ANCA)-associated disease among other manifestations can underlie rapidly progressive glomerulonephritis (RPGN), with crescentic and necrotizing GN. Differences in pathogenic immune mechanisms in RPGN may provide differences in the renal expression of adhesion molecules mediating these lesions.
Methods
Renal intercellular adhesion molecule 1 (ICAM-1; CD54) and vascular cell adhesion molecule 1 (VCAM-1; CD106) were assessed in 40 patients with type I RPGN (anti-glomerular basement membrane antibodies, n = 4), type II (immune complexes, n = 17), and type III (ANCA, n = 19). Enzyme-linked immunosorbent assay (ELISA) for detection of immunoglobulin G antibodies against the Goodpasture’s antigen and indirect immunofluorescence and ELISA for myeloperoxidase (MPO) and proteinase 3 (PR3) were performed for ANCA testing. Ten normal renal tissues were used as controls. Relationships between ICAM-1 and VCAM-1, histopathologic features, and CD18, CD14, and CD3 cells were analyzed.
Results
Abnormal ICAM-1 and VCAM-1 in tubule was seen in >80% of biopsies with RPGN. Abnormal VCAM-1 in glomerular tuft was seen in >60% of biopsies with RPGN. Glomerular ICAM-1 was associated with less glomerulosclerosis (χ 2 = 6.719, p = 0.01), less interstitial fibrosis (χ 2 = 4.322, p < 0.05), and less tubular atrophy (χ 2 = 8.547, p < 0.005). Glomerular VCAM-1 was associated with glomerular leukocyte infiltration (χ 2 = 4.698, p < 0.05). Glomerular tuft stains of ++/+++ for VCAM-1 was observed in 10% from MPO-ANCA-GN patients but in 60% from PR3-ANCA-GN (Fi = 8.538, p = 0.03).
Conclusions
The following conclusions can be made from this study. (1) The renal expression of ICAM-1 and VCAM-1 is upregulated in RPGN, and this is associated with the histological activity. (2) De novo expression of VCAM-1 on glomerular tuft suggests that endothelial cells play a role in RPGN. (3) De novo tubular expression of ICAM-1 and VCAM-1 suggests that epithelial cells may participate in adhesive interactions in RPGN. (4) De novo expression of VCAM-1 at the glomerular tuft in PR3-ANCA positive patients seems greater than in MPO-ANCA positive patients, which suggests that testing specific immune activation mechanisms may play a role in ANCA-associated GN.
Similar content being viewed by others
References
Yang N, Isbel NM, Nikolic-Paterson DJ, Li Y, Ye R, Atkins RC, et al. Local macrophage proliferation in human glomerulonephritis. Kidney Int. 1998;54:143–51.
Erwig LP, Rees AJ. Rapidly progressive glomerulonephritis. J Nephrol. 1999;12(suppl 2):111–9.
Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301–14.
Cibulsky AV. Adhesion molecules in renal diseases. In: Paul LC, Issekutz TB, editors. Adhesion molecules in health and disease. New York: Marcel Decker; 1997. p. 619–25.
Adler S, Brady HR. Cell adhesion molecules and the glomerulopathies. Am J Med. 1999;107:371–86.
Arrizabalaga P, Mampaso F. Integrins and glomerulonephritis. In: Esbrit P, Alvarez-Arroyo MV, editors. Inflammation and chronic disease. Kerala: Transworld Research Network; 2006. p. 67–87.
Bacon A, Moots RJ, Exley A, Luqmani R, Rasmussen N. Vital assessment of vasculitis. Clin Exp Rheumatol. 1995;13:275–8.
Wiik A, Rasmussen N, Weislander J. Methods to detect autoantibodies to neutrophilic granulocytes. In: Van Venrooig WJ, editor. Manual of biological markers of disease. Dordrecht: Kluwe; 1993. p. 1–14.
Arrizabalaga P, Solé M, Ascaso C, Quintó Ll. Intercellular adhesion molecule-1 mediated interactions and leucocyte infiltration in IgA nephropathy. Nephrol Dial Transplant. 1997;12:2258–62.
Engel P, Serra C, Acevedo G, Vilella R, Gallart T. Involvement of CD18 and CD54 in the mixed lymphocyte reaction to leukemic CD5+ B lymphocytes. Immunology 1992;11:21–31.
Spertini O, Luscinskas FW, Kansas GS, Munro JM, Griffin JD, Gimbrone MA, et al. Leukocyte adhesion molecule-1 interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol. 1991;147:2565–73.
Cobbold S, Hale G, Waldmann H. Non-lineaje, LFA-1 family, and leucocyte common antigens: new and previously defined clusters. In: McMichael AJ, editor. Leucocyte typing III. Oxford: Butler and Tanner; 1987. p. 788–803.
Bernstein ID, Self S. Joint report of the myeloid section of the Second International Workshop on human leucocyte differentiation antigens. In: Reinherz EL, Haynes BF, Nadler LM, Bernstein ID, editors. Leucocyte typing II. New York: Springer; 1986. p. 1–25.
Hir ML, Besse-Eschmann V. A novel mechanism of nephron loss in a murine model of crescentic glomerulonephritis. Kidney Int. 2003;63:591–9.
Khan SB, Allen AR, Bhangal G, Smith J, Lobb RR, Cook HT, et al. Blocking VLA-4 prevents progression of experimental crescentic glomerulonephritis. Nephron Exp Nephrol. 2003;95:100–10.
Arrizabalaga P, Solé M, Abellana R, de las Cuevas X, Soler J, Pascual J, et al. Tubular and interstitial expression of ICAM-1 as a marker of renal injury in IgA nephropathy. Am J Nephrol. 2003;23:121–8.
Roy-Chaudhury P, Wu B, King G, Campbell M, MacLeod AM, Haites EN, et al. Adhesion molecule interactions in human glomerulonephritis: importance of the tubulointerstitium. Kidney Int. 1996;49:127–34.
Odobasic D, Kitching AR, Semple TJ, Timoshanko JR, Tipping PG, Holdsworth SR. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis. J Am Soc Nephrol. 2005;16:2012–22.
Schulz H, Karau A, Filsinger S, Schoels M, Kabelitz D, Richter R, et al. Tubular epithelial cells as accessory cells for superantigen-induced T cell activation. Exp Nephrol. 1998;6:67–73.
Wu Q, Jinde K, Endoh M, Sakai H. Costimulatory molecules CD80 and CD86 in human crescentic glomerulonephritis. Am J Kidney Dis. 2003;41:950–61.
Arrizabalaga P, Sans A, Torras A, Darnell A, Revert L. Monoclonal antibody analysis of crescentic membranous glomerulonephropathy. Am J Nephrol. 1998;18:77–82.
Ferrario F, Rastaldi MP. Histopathological atlas of renal diseases: ANCA-associated vasculitis (second part). J Nephrol. 2005;18:217–20.
Moon KC, Park SY, Kim HW, Hong HK, Lee HS. Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in human crescentic glomerulonephritis. Histopathology 2002;41:158–65.
Patey N, Lesavre P, Halbwachs-Mecarelli L, Noël LH. Adhesion molecules in human crescentic glomerulonephritis. J Pathol. 1996;179:414–20.
Pall AA, Howie AJ, Adu D, Richards GM, Inward CD, Milford DV, et al. Glomerular vascular cell adhesion molecule-1 expression in renal vasculitis. J Clin Pathol. 1996;49:238–42.
Rastaldi MP, Ferrario F, Crippa A, Dell’Antonio G, Casartelli D, Grillo C, et al. Glomerular monocyte-macrophage features in ANCA-positive renal vasculitis and cryoglobulinemic nephritis. J Am Soc Nephrol. 2000;11:2036–43.
Ferrario F, Rastaldi MP. Histopathological atlas of renal diseases: ANCA-associated vasculitis (first part). J Nephrol. 2005;18:113–6.
Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61:80–9.
Hsieh SC, Yu HS, Cheng SH, Li KJ, Lu MC, Wu CH, et al. Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils. Clin Rheumatol. 2007;26:216–24.
Preston GA, Yang JJ, Xiao H, Falk RJ. Understanding the pathogenesis of ANCA: where are we today. Cleve Clin J Med. 2002;69:SII51–4.
Acknowledgments
The authors thank Dr. R. Vilella and P. Engel for generous gifts of CD54, CD106, and CD14 monoclonal antibodies and N. Babot for excellent immunohistochemistry.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arrizabalaga, P., Solé, M., Abellana, R. et al. Renal Expression of Adhesion Molecules in Anca-Associated Disease. J Clin Immunol 28, 411–419 (2008). https://doi.org/10.1007/s10875-008-9215-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-008-9215-2